Innodem Neurosciences: ETNA DEVICE FROM THE LEADING DIGITAL

MONTREAL, May 31, 2022 /PRNewswire/ -- Innodem Neurosciences, a leading provider of innovation and technology for the convergence of neurosciences, digital health, pharmaceutical and artificial

Related Keywords

New York , United States , Montreal , Quebec , Canada , Japan , Tokyo , Washington , Prnewswire Innodem Neurosciences , Marc Reeves , Embs Gmbs , Kostenloser Wertpapierhandel , Alyssa Howard , Innodem Neurosciences , Tim Marjenin , Us Food Drug Administration , Head Of Neurology Regulatory Affairs , Clinical Research Organization , Eye Movement Biomarkers Embs , Mcgill University , Business Development , Eye Tracking Neurological Assessment , Multiple Sclerosis , Eye Movement Biomarkers , Gaze Mapping Biomarkers , Software Asa Medical Device , Vice President , Neurology Regulatory Affairs , Chief Business Officer , Frontotemporal Dementia , Cancer Related Cognitive Impairment , Senior Director , Innodem , Neurosciences , Aetna , Device , Rom , Reading , Digital , Health , Company , Eceives , Breakthrough , Resignation , Multiple , Clerosis ,